Both CD133+ as well as CD133− cells remained highly proliferative with rapid tumor growth even at numbers as low as 5000 cells per injection, confirming that CD133 alone does not sufficiently define tumor initiating cells (Fig. 3d). The gene discussed is PROM1; the disease is neoplasm.